← All stocks

DiaMedica Therapeutics Inc.

DMAC No buying or selling
CIK 0001401040 #3414 in the set updated 18 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

9 insiders · 0 transactions
1.7×

Rick Pauls holds only 1.7 times base salary in stock. $1.10M of shares against $645.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Rick Pauls last reported holding, valued at $8.57, the price Common Shares was last bought or sold at on the open market here, on 25 Nov 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
STAHLBERG JAN
10% owner
8,825,742
$75.68M
+69.0%
Von Koch Thomas
10% owner
8,383,577
$71.89M
+51.7%
JACINTO RICHARD II
10% owner
4,958,823
$42.52M
+8.8%
Giuffre Randall Michael
Director
398,587
$3.42M
+9.3%
Pilnik Richard D.
Director
312,995
$2.68M
+12.3%
Pauls Dietrich John
President & CEO
128,791
$1.10M
+87.8%
Parsons James T.
Director
97,949
$839.90K
+63.4%
Semba Charles Pauling
Director
47,963
$411.28K
+22.0%
Kuntz Richard
Director
24,210
$207.60K
+69.5%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 11 Dec 2018